Transsynaptic tracing has become a powerful tool used to analyze central efferents that regulate peripheral targets through multi-synaptic circuits. This approach has been most extensively used in the brain by utilizing the swine pathogen pseudorabies virus (PRV)
Introduction
Transsynaptic tracing has become a powerful tool used to analyze central efferents that regulate peripheral targets through multi-synaptic circuits. This approach has been most extensively used in the rodent brain by utilizing the swine pathogen pseudorabies virus (PRV), especially the attenuated strain PRV-Bartha first described in 1961 12 .
Here, we present a protocol for identifying the motor cortical representation of specific muscles or muscle groups using a recombinant pseudorabies virus strain (PRV152) expressing the enhanced green fluorescent protein (eGFP) reporter gene 2 . The described method exploits the behavior of neurotropic viruses, which produce infectious progeny that cross synapses to infect other neurons within a functional circuit 3, 4, 13 . PRV152, which is isogenic with PRV-Bartha, only crosses synapses retrogradely through the hierarchical sequence of synaptic connections away from the infection site 3, 5 . By precisely controlling the peripheral site of infection it is possible to limit the entry of the virus into the brain through a specific subset of motor neurons. As the virus sequentially infects chains of connected neurons, the resulting pattern of eGFP signal throughout the brain will then resolve the network of neurons that are connected to the initially infected cells.
An additional advantage of using virus for neural tracing is the amplification of the reporter protein (eGFP in this case) within infected cells. This signal amplification provides a level of sensitivity that allows detection of even sparse projections. For example, a sparse projection from vibrissa motor cortex to the facial motor neurons controlling the whiskers was found in rats using virally expressed green fluorescent protein 14 ; previous studies failed to find this projection using classical tracers without reporter gene amplification 11, 15 . Unfortunately, many viral tracing vectors, like the one used in the cited study, do not cross synapses, thereby limiting their use for tracing multi-synaptic circuits.
While presenting distinct advantages for identifying the network of cells participating in a motor circuit, the distributed nature of transsynaptic tracing with PRV-152 makes interpreting specific connections within the circuit difficult. Therefore, we present a simple method for validating specific connections within circuits identified using PRV-152 by double-labeling using biotinylated dextran amines (BDA) and cholera toxin subunit b (CTb). The combined use of BDA and CTb is a well-established approach for tracing connections between specific sets of neurons [6] [7] [8] 11 . When used together, these two tracers can be visualized in the same section using a two-color DAB (3, 3'-diaminobenzidine) procedure 16 . High molecular weight BDA (BDA10kDa) was selected for this protocol because it yields detailed labeling of neuronal processes 6, 7, 9 . Additional advantages of BDA10kDa include the following: it is preferentially transported in the anterograde direction [6] [7] [8] ; it can be delivered by iontophoretic or pressure injection [6] [7] [8] ; it can be visualized by a simple avidin-biotinylated HRP (ABC) procedure 17 ; and it can be imaged by light or electron microscopy
Surgical Preparation for Injection of Tracers into Brain Regions Discovered by PRV Tracing
1. Induce general anesthesia by intramuscular injection of ketamine-xylazine (100 mg/kg ketamine; 10 mg/kg xylazine) and maintain an appropriate anesthetic plane using isofluorane. 2. Protect the corneas with an opthalmic ointment. 3. Fix the head in an appropriate stereotaxic frame. 4. Prepare the surgical site according to aseptic technique by trimming hair and disinfecting the site with alternating scrubs of Betadine and 70% alcohol (minimum of 3 cycles). 5. Make a scalp incision and retract the skin over the brain region of interest. 6. Perform a small craniotomy at the appropriate stereotaxic coordinates. For example, the coordinates for laryngeally connected motor cortex identified by PRV tracing in an adult mouse are 1.2 mm lateral and 0.2 mm rostral to Bregma.
Injection of Biotinylated Dextran Amines into Brain
1. Prepare 7.5% biotinylated dextran amines (BDA) by dissolving 25 mg of BDA (10,000 MW) in 333 µl of sterile saline. 2. Load the Nanoject II micropipette system with sufficient BDA solution for the planned injections. 3. Slowly clear the dead space and verify that solution is exiting the micropipette tip. 4. Using a stereotaxic micropositioning device carefully lower the micropipette tip into the brain region of interest and slowly inject BDA. Adjust the injection rate depending on the size of the region to be labeled. For example, 12 injections of 4.6 nl should made be at four different locations 0.2 mm apart (rostro-caudal direction) to cover the laryngeally connected motor cortex in adult mice. The final injection volume should be adjusted according to the size of the brain region of interest, keeping in mind that label may spread from the injection core by diffusion through brain tissue and along the processes of labeled neurons. 5. Seal the craniotomy using dental cement, and close the scalp wound using VetBond tissue adhesive. 6. Monitor the animal until sternal recumbency and provide analgesia, food, water, and care as required by your institutional animal use guidelines.
Injection of Cholera Toxin Subunit b into Muscle
1. Prepare 1% Cholera Toxin subunit b (CTb) by dissolving 1 mg of CTb in 100 µl of sterile saline. 2. Six days after BDA injection into the brain, perform the surgical preparation as described above for PRV injections into muscle. 3. Load the 10 µl NanoFil microsyringe system with CTb solution, attach a 34 G stainless steel needle, and carefully mount it on the stereotaxic device. 4. Perform the microinjections into the muscle(s) of interest as previously described for PRV. 5. Monitor the animal until sternal recumbency and provide analgesia, food, water, and care as required by your institutional animal use guidelines. 6. Three days after CTb injection, sacrifice the animal by pentobarbital overdose and perfuse transcardially with 0.9% saline followed by 4% formaldehyde in 0.1 M PBS. 7. Remove and post-fix the brain in 4% formaldehyde for 24 hr. 8. Cryoprotect the brain in phosphate buffer containing 30% sucrose for at least 48 hr. 
Detection of BDA and CTb in the Same Sections

Figure 1a
shows neurons infected with PRV152 expressing eGFP in nucleus ambiguus, which houses the laryngeal motor neurons, 94 hr after injection of PRV152 into two of the seven laryngeal muscles. Because the virus entered the brain through neurons that innervate the infected muscles, other phonatory motor neuron pools, such as the hypoglossal nucleus, do not express eGFP (Figure 1b) . Figure 2 shows retrograde transport of the virus to 2 nd order brainstem neurons subsequent to primary infection in nucleus ambiguus. The injection was unilateral, and the resulting pattern of label in the brainstem shows infection of the ipsilateral nucleus ambiguus and solitary nucleus (Figure 2a) . Reticular interneurons were also infected and stained strongly for eGFP (Figure 2b) . These interneurons connect various structures, including the phonatory motor neuron pools and the contralateral nucleus ambiguus; however, their efferent targets remain unlabeled because the virus only spreads in the retrograde direction. Figure 3 shows infected premotor neurons in the motor cortex expressing eGFP contralateral to the peripheral injection site. Because PRV152 spreads through multi-synaptic circuits impinging on laryngeal motor neurons in nucleus ambiguus, it can be assumed that only the population of cells that compose the motor cortical representation of the laryngeal musculature were infected. The lack of eGFP signal in the rest of the section shown (and most of the forebrain not shown) demonstrates the specificity of the labeling. 
Discussion
There are a number of issues that must be taken into consideration when planning an experiment using PRV152 4, 21 . Most importantly, pseudorabies virus is lethal. As mentioned previously, great apes, including humans are not susceptible to infection, but appropriate care must be exercised to protect other animals. Adult mice typically survive five to seven days after inoculation with the attenuated PRV152 strain. Therefore, PRV152 is not appropriate for experiments that require survival times longer than one week. Moreover, infected animals typically display signs of illness during the survival period, thereby limiting the utility of PRV152 for experiments requiring observation of normal behavior.
Additionally, PRV152 triggers a cytotoxic immune response . Therefore, we recommend using titers above 1 x 10 7 pfu/ml and keeping aliquoted virus at -80°C until it is used to maintain its infectivity. Even when using a high titer, one should keep in mind that not all cell types may be permissive for infection. Therefore, the cells identified by PRV tracing may not be completely representative of the inputs to an infected target.
The described method focuses on the utility of PRV for analyzing central efferents regulating peripheral targets, specifically muscles, through multi-synaptic circuits. Other neural circuits, such as visual and autonomic 24 , are well suited for this technique because they can also be infected by peripheral inoculation. However, PRV can be used effectively for direct injection into the central nervous system when some issues are carefully considered, as discussed extensively in a prior review 3 . Those authors mention that PRV-Bartha and related strains extensively fill the dendritic arbors of infected neurons, making PRV152 well suited for identifying afferents to distal dendrites. This property of the virus makes the described technique particularly useful for deducing a preliminary list of inputs to distal dendrites located outside of the cell body region that is typically studied with conventional tracers.
When tracing from peripheral targets, sympathetic innervation should be considered a possible confound. Therefore, we recommend initially comparing labeling patterns in normal and sympathectomized animals to determine whether PRV labeling of sympathetic inputs will affect interpretation of the results.
Signal in infected cells from eGFP expressed by PRV152 can be imaged directly using fluorescence microscopy without the need for immunohistochemistry; however, this signal is subject to photo-bleaching and degrades over time. The main advantage of immunohistochemistry combined with DAB staining for tract tracing is the permanent nature of the reaction products. While it is also possible to use antibodies against viral proteins to detect infected cells, different viral elements will not necessarily co-localize with each other 25 or with the eGFP signal. Therefore, we recommend using antibodies against eGFP to preserve the labeling pattern observed by fluorescence.
Because all afferents to an infected cell are likely to become conduits for transsynaptic passage of virus, including those that contact distal dendrites, we considered it important to select a conventional tracer that reliably stains such dendrites for subsequent confirmation of relays in the identified circuit. We selected CTb for this purpose, and found that it provides good staining of the dendrites and strong contrast with both the surrounding neuropil and the descending axons from the motor cortex. Although it is possible to reverse the coloration of the stained axons and cell bodies (BDA = brown; CTb = black), we find that black provides the best contrast for visualizing fine caliber axons.
